Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50583 (
asymmetrical
)
12,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The preovulatory LH surge is triggered when the circadian pacemaker, the bilateral suprachiasmatic nucleus (SCN), stimulates the GnRH system in the presence of high estrogen concentrations (positive feedback). Importantly, during the remainder of the estrous cycle, estradiol inhibits LH release via negative feedback. We have recently documented the presence of a novel mammalian
RFamide-related peptide
(
RFRP
), a putative gonadotropin-inhibitory hormone (GnIH), that presumably acts upstream of GnRH to modulate the negative feedback effects of estrogen. The present series of studies used female Syrian hamsters to examine the possibility that, in addition to driving the LH surge positively, the SCN concomitantly coordinates the removal of steroid-mediated
RFRP
inhibition of the gonadotropic axis to permit the surge. We found that the SCN forms close appositions with
RFRP
cells, suggesting the possibility for direct temporal control of
RFRP
activity. During the time of the LH surge, immediate-early gene expression is reduced in
RFRP
cells, and this temporal regulation is estrogen dependent. To determine whether projections from the SCN regulate the timed reduction in activation of the
RFRP
system, we exploited the phenomenon of splitting. In split animals in which the SCN are active in antiphase, activation of the
RFRP
system is
asymmetrical
. Importantly, this asymmetry is opposite to the state of the GnRH system. Together, these findings point to novel circadian control of the
RFRP
system and potential participation in the circuitry controlling ovulatory function.
...
PMID:Alterations in RFamide-related peptide expression are coordinated with the preovulatory luteinizing hormone surge. 1856 14